Sam Jon Connon - Comment

Document ID: FDA-2012-N-1148-0048
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 04 2013, at 12:00 AM Eastern Standard Time
Date Posted: March 8 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: January 3 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: January 16 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-82x5-2kjm
View Document:  View as format xml

View Comment

I respectfully ask that a suggestion be offered for over the counter nicotine control products to be covered by the Health Insurance program adopted by the United States Legislature. I would also like to ask that over the counter nicotine control products have instructions which will allow dual use of these products for a tobacco user. The use of multiple products for assisting the addicted tobacco user to tolerate the nicotine withdrawal while learning a more constructive behavior is very much needed. I would also encourage that exploration of other nicotine over the counter products be evaluated to see if these can assist. One such product is the oral nicotine spray offered in Canada. For the addicted tobacco user cost is a factor. The tobacco user does not want to spend more money on products until his/her confidence level is elevated. This cannot be done successfully until the tobacco user has access to nicotine replacement products and counseling for at least the first 90 days. It also may be necessary for some tobacco users to utilize nicotine replacement products for longer than 90 days in order to find success in the behavior modification.

Related Comments

    View All
Total: 50
Owen R. Sechrist - Comment
Public Submission    Posted: 02/28/2013     ID: FDA-2012-N-1148-0028

Jan 16,2013 11:59 PM ET
Joseph Varano - Comment
Public Submission    Posted: 03/11/2013     ID: FDA-2012-N-1148-0056

Jan 16,2013 11:59 PM ET
Sam Jon Connon - Comment
Public Submission    Posted: 03/08/2013     ID: FDA-2012-N-1148-0048

Jan 16,2013 11:59 PM ET
Russell Andrew Hauss - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2012-N-1148-0064

Jan 16,2013 11:59 PM ET
Christy Kuppler - Comment
Public Submission    Posted: 03/13/2013     ID: FDA-2012-N-1148-0060

Jan 16,2013 11:59 PM ET